相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD
Alan K. Davis et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
Alan K. Davis et al.
JAMA PSYCHIATRY (2021)
Age at migration and the risk of psychotic disorders: a systematic review and meta-analysis
K. K. Anderson et al.
ACTA PSYCHIATRICA SCANDINAVICA (2020)
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle Agin-Liebes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Tripping on nothing: placebo psychedelics and contextual factors
Jay A. Olson et al.
PSYCHOPHARMACOLOGY (2020)
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
Albert Garcia-Romeu et al.
FRONTIERS IN PSYCHIATRY (2020)
Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation
Richard J. Zeifman et al.
FRONTIERS IN PSYCHIATRY (2020)
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study
Brian T. Anderson et al.
ECLINICALMEDICINE (2020)
The use of the psychological flexibility model to support psychedelic assisted therapy
Rosalind Watts et al.
JOURNAL OF CONTEXTUAL BEHAVIORAL SCIENCE (2020)
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety
Alan K. Davis et al.
JOURNAL OF CONTEXTUAL BEHAVIORAL SCIENCE (2020)
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes et al.
PSYCHOLOGICAL MEDICINE (2019)
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety
Alan K. Davis et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Albert Garcia-Romeu et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Michael C. Mithoefer et al.
PSYCHOPHARMACOLOGY (2019)
Psychiatry & the psychedelic drugs. Past, present & future
James J. H. Rucker et al.
NEUROPHARMACOLOGY (2018)
Psychedelic use and intimate partner violence: The role of emotion regulation
Michelle S. Thiessen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Allison A. Feduccia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman et al.
FRONTIERS IN PHARMACOLOGY (2018)
MDA, MDMA, and other mescaline-like substances in the US military's search for a truth drug (1940s to 1960s)
Torsten Passie et al.
DRUG TESTING AND ANALYSIS (2018)
Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy
Peter S. Hendricks
INTERNATIONAL REVIEW OF PSYCHIATRY (2018)
Alterations of consciousness and mystical-type experiences after acute LSD in humans
Matthias E. Liechti et al.
PSYCHOPHARMACOLOGY (2017)
An online survey of tobacco smoking cessation associated with naturalistic psychedelic use
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Robin L. Carhart-Harris et al.
SCIENTIFIC REPORTS (2017)
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)
Matthew M. Nour et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2016)
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
Theresa M. Carbonaro et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
Frederick S. Barrett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
Ido Hartogsohn
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
Rainer Kraehenmann et al.
NEUROIMAGE-CLINICAL (2016)
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Frederick S. Barrett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013
Zachary Steel et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
Harvey A. Whiteford et al.
LANCET (2013)
PTSD as Meaning Violation: Testing a Cognitive Worldview Perspective
Crystal L. Park et al.
PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY (2012)
Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin
Katherine A. MacLean et al.
JOURNAL FOR THE SCIENTIFIC STUDY OF RELIGION (2012)
Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner
Michael Lyvers et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Katherine A. MacLean et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
Antidepressants versus placebo for depression in primary care
B. Arroll et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Comorbidity between substance use disorders and psychiatric conditions
Marc A. Schuckit
ADDICTION (2006)
Psychological and cognitive effects of long-term peyote use among Native Americans
JH Halpern et al.
BIOLOGICAL PSYCHIATRY (2005)
Measuring experiential avoidance: A preliminary test of a working model
SC Hayes et al.
PSYCHOLOGICAL RECORD (2004)
Gaps in accessing treatment for anxiety and depression: Challenges for the delivery of care
KA Collins et al.
CLINICAL PSYCHOLOGY REVIEW (2004)
Sacred changes: Spiritual conversion and transformation
A Mahoney et al.
JOURNAL OF CLINICAL PSYCHOLOGY (2004)
分享论文
